Publicacións nas que colabora con Alberto Fernández Villar (14)

2021

  1. Alterations in respiratory function test three months after hospitalisation for covid-19 pneumonia: Value of determining nitric oxide diffusion

    Journal of Clinical Medicine, Vol. 10, Núm. 10

2020

  1. Comparison of bisulfite pyrosequencing and methylation-specific qPCR for methylation assessment

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-13

2019

  1. Methylation assessment for the prediction of malignancy in mediastinal adenopathies obtained by endobronchial ultrasound-guided transbronchial needle aspiration in patients with lung cancer

    Cancers, Vol. 11, Núm. 10

2017

  1. Highly sensitive marker panel for guidance in lung cancer rapid diagnostic units

    Scientific Reports, Vol. 7

  2. Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis

    BMC Cancer, Vol. 17, Núm. 1

2016

  1. HLA-DQ B1*0201 and A1*0102 alleles are not responsible for antituberculosis drug-induced hepatotoxicity risk in Spanish population

    Frontiers in Medicine, Vol. 3, Núm. AUG

2014

  1. Viability of Lymph Node Samples Obtained by Echobronchoscopy in the Study of Epigenetic Alterations in Patients With Lung Cancer

    Archivos de Bronconeumologia, Vol. 50, Núm. 6, pp. 213-220

2012

  1. Prognostic value of aberrant hypermethylation in pleural effusion of lung adenocarcinoma

    Cancer Biology and Therapy, Vol. 13, Núm. 14, pp. 1436-1442

  2. Valor diagnóstico de la determinación de las alteraciones epigenéticas en el estudio del derrame pleural maligno

    Investigación: cultura, ciencia y tecnología, Núm. 7, pp. 48-54

2011

  1. N-acetyltransferase 2 polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity in Caucasians

    International Journal of Tuberculosis and Lung Disease, Vol. 15, Núm. 10, pp. 1403-1408

2010

  1. Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population.

    Pharmacogenomics

  2. Letter to the editor

    Pharmacogenomics

2009

  1. Glutathione S-transferase M1 and T1 null genotypes increase susceptibility to drug-induced liver injury

    Hepatology

2008

  1. Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population

    Liver International, Vol. 28, Núm. 6, pp. 835-839